Pfizer building’s column scare tests Midtown East’s biggest conversion bet
All eyes were on Midtown East last week after steel columns buckled inside the Pfizer building conversion project, forcing evacuations at the site and nearby buildings on Tuesday. The structural failures at 235 East 42nd Street — where Nathan Berman’s MetroLoft Management and investor David Werner are converting the pharmaceutical firm’s former headquarters into 1,600 apartments — captured national headlines and sparked surprise among industry players, as well as a probe by the city’s Department of Investigation into their cause. Though the building has since been stabilized, its near-collapse — and the spotlight it attracted — also raises questions about […]
This article originally appeared on The Real Deal. Click here to read the full story.
Categories
Recent Posts

The Deals Behind Australia’s Boom In Branded
Residences

Ran the Numbers but Nothing Cash Flows? What to Do Next
(Rookie Reply)

The Nothing Plan: Group aims to stop 6,000 Brooklyn
homes

Real estate will learn to cope with COPA

NY Dirt: COPA puts nonprofits first, sidelining
investors

StreetEasy goes on the offense in listings battle

The 15 markets where home sellers are cutting prices the
fastest

Real Estate Documents and Details to Keep Track of After
Closing

More Than a Floor Plan: How a House Layout Affects Daily
Life

How Much Do Rental Properties Make? Real Numbers From
Investors


